PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsCorneal diseases
MeSH D003316 - corneal diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005128:Eye diseases
0 Companies
0 Drugs
Success rate
D003316: 
Corneal diseases
$
Success rate
D003317:Hereditary corneal dystrophies
0 Companies
0 Drugs
Success rate
D003318:Corneal opacity
0 Companies
0 Drugs
Success rate
D007634:Keratitis
D007640:Keratoconus
0 Companies
0 Drugs
Success rate
D014141:Trachoma
D015715:Corneal edema
0 Companies
0 Drugs
Success rate
D016510:Corneal neovascularization
0 Companies
0 Drugs
Success rate
D055954:Corneal endothelial cell loss
0 Companies
0 Drugs
Success rate
D057108:Corneal wavefront aberration
0 Companies
0 Drugs
Success rate
D057129:Iridocorneal endothelial syndrome
0 Companies
0 Drugs
Success rate
D065306:Corneal injuries
0 Companies
0 Drugs
Success rate
D000092423:Limbal stem cell deficiency
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
SantenCiclosporin Ikervis  2015-03-19   
Clinical Trials
Historical Success Rate
Phase 1
100%
9/9
Phase 2
0%
0/9
Phase 3
100%
3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use